Viking Therapeutics plans $400M raise via stock and note offerings
Go back to Viking Therapeutics plans $400M raise via stock and note offerings| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 35.56 -1.19 (3.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.75 | 52 Week High | $5.17 | |||
| Open | $37.80 | 52 Week Low | $0.94 | |||
| Day High | $39.05 | P/E | N/A | |||
| Day Low | $35.10 | EPS | $0.00 | |||
| Volume | 13,616,861 | |||||
